⌘K

Login Start Free

Home/Filings/4/0001127602-24-016776

4//SEC Filing

ASELAGE STEVE 4

Accession 0001127602-24-016776

CIK 0000882796other

View on SEC.gov Company Profile

Filed

May 28, 8:00 PM ET

Accepted

May 29, 4:16 PM ET

Size

4.9 KB

Accession

0001127602-24-016776

Insider Transaction Report

Form 4

Period: 2024-05-24

BIOCRYST PHARMACEUTICALS INCBCRX

Director

Transactions

Purchase
Common Stock
2024-05-24$6.40/sh+2,500$16,000→ 2,500 total(indirect: By Trust)

Holdings

Common Stock
63,339

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001221599

Filing Metadata

Form type: 4
Filed: May 28, 8:00 PM ET
Accepted: May 29, 4:16 PM ET
Size: 4.9 KB

View on SEC.gov